HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

47 hedge funds and large institutions have $51.1M invested in abrdn Life Sciences Investors in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

7% more capital invested

Capital invested by funds: $47.6M → $51.1M (+$3.54M)

1.16% less ownership

Funds ownership: 12.74% → 11.58% (-1.2%)

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.08M
2
+$1.05M
3
+$983K
4
RJA
Raymond James & Associates
Florida
+$293K
5
FHA
Flagship Harbor Advisors
Massachusetts
+$288K

Top Sellers

1
-$1.96M
2
-$825K
3
-$805K
4
NIM
Needham Investment Management
New York
-$465K
5
Wells Fargo
Wells Fargo
California
-$196K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$237K
27
$235K
28
$228K
29
$213K
30
$208K
31
$63K
32
$54K
33
$53K
34
$42K
35
$38K
36
$29K
37
$28K
38
$22K
39
$20K
40
$17K
41
$15K
42
$14K
43
$11K
44
$1K
45
$5
46
–
47
–
1
2